Coenzyme Q10 Prevents Oxidative Stress and Fibrosis in Isoprenaline Induced Cardiac Remodeling in Aged Rats

Overview

Journal BMC Pharmacol Toxicol

Publisher Biomed Central

Specialty Pharmacology

Date 2017 Apr 22

PMID 28427467

Citations 25

Authors

Anayt Ulla

Mustafe Khalid Mohamed

Biswajit Sikder

Afm Towheedur Rahman

Farzana Akther Sumi

Murad Hossain

Hasan Mahmud Reza

G M Sayedur Rahman

Md Ashraful Alam

Affiliations

Soon will be listed here.

Abstract

Background: The objective of the present study aimed to investigate the effect of CoQ10 treatment on isoprenaline (ISO)-induced cardiac remodeling in rats.

Methods: Rats were divided into three groups namely Control group, ISO treated group and CoQ10 + ISO treated group, each consisting of 6 rats. The cardiac specific CK-MB, AST, ALT activity and other oxidative stress parameters were estimated in heart and kidneys. Additionally histological examination was also performed to visualize the inflammatory cells infiltration and fibrosis in both tissues.

Results: Administration of ISO resulted in an increase in the heart-to-body weight (HW/BW) ratio and an also increased the serum CK-MB, AST and ALT enzyme activity. Serum levels of lipid peroxidation products, and oxidative stress markers showed significant increase in ISO-treated rats. Histopathological examination of heart tissue revealed focal areas of endocardium degeneration, mononuclear cells infiltration, fibrous tissue deposition, and increased thickness of the myocardium of left ventricle. Similar degeneration was also found in kidneys. Treatment with CoQ10 (100 mg/kg) significantly improved the oxidative stresses in ISO treated rats. Moreover, CoQ10 treatment prevented inflammatory cells infiltration and reduced fibrosis in ISO administered rats.

Conclusion: In conclusion, our study provides evidence that CoQ10 may prevent the development of cardiac remodeling, and fibrosis in ISO administered rats.

Citing Articles

Therapeutic effect of coenzyme-Q10 pretreatment on isoprenaline-induced cardiogenic hepatorenal complications in rats.

Chidebe E, Moke E, Asiwe J, Ben-Azu B, Demaki W, Oritsemuelebi B Int J Physiol Pathophysiol Pharmacol. 2025; 16(6):126-137.

PMID: 39850246 PMC: 11751547. DOI: 10.62347/PFXZ9903.

Cardioprotective action of apocynin in isoproterenol-induced cardiac damage is mediated through Nrf-2/HO-1 signaling pathway.

Rahman M, Alimullah M, Yasmin T, Akhter N, Ahmed I, Khan F Food Sci Nutr. 2024; 12(11):9108-9122.

PMID: 39619949 PMC: 11606833. DOI: 10.1002/fsn3.4465.

Evaluation of Antioxidant Effects of Coenzyme Q10 against Hyperglycemia-Mediated Oxidative Stress by Focusing on Nrf2/Keap1/HO-1 Signaling Pathway in the Liver of Diabetic Rats.

Samimi F, Baazm M, Nadi Z, Dastghaib S, Rezaei M, Jalali-Mashayekhi F Iran J Med Sci. 2024; 49(10):661-670.

PMID: 39449772 PMC: 11497326. DOI: 10.30476/ijms.2023.100078.3222.

Protective effects of l-carnitine on isoprenaline -induced heart and kidney dysfunctions: Modulation of inflammation and oxidative stress-related gene expression in rats.

Chisty T, Sarif S, Jahan I, Ismail I, Chowdhury F, Siddiqua S Heliyon. 2024; 10(3):e25057.

PMID: 38322874 PMC: 10845729. DOI: 10.1016/j.heliyon.2024.e25057.

Ameliorating impact of coenzyme Q10 on the profile of adipokines, cardiomyopathy, and hematological markers correlated with the glucotoxicity sequelae in diabetic rats.

Jbrael Y, Hamad B PLoS One. 2024; 19(1):e0296775.

PMID: 38227584 PMC: 10790996. DOI: 10.1371/journal.pone.0296775.

References

BLIZNAKOV E . Cardiovascular diseases, oxidative stress and antioxidants: the decisive role of coenzyme Q10. Cardiovasc Res. 1999; 43(1):248-9. DOI: 10.1016/s0008-6363(99)00128-5. View

Cohn J, Ferrari R, Sharpe N . Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling. J Am Coll Cardiol. 2000; 35(3):569-82. DOI: 10.1016/s0735-1097(99)00630-0. View

Maynard S, Menown I, Adgey A . Troponin T or troponin I as cardiac markers in ischaemic heart disease. Heart. 2000; 83(4):371-3. PMC: 1729379. DOI: 10.1136/heart.83.4.371. View

Lefkowitz R, Rockman H, Koch W . Catecholamines, cardiac beta-adrenergic receptors, and heart failure. Circulation. 2000; 101(14):1634-7. DOI: 10.1161/01.cir.101.14.1634. View

Dallner G, SINDELAR P . Regulation of ubiquinone metabolism. Free Radic Biol Med. 2000; 29(3-4):285-94. DOI: 10.1016/s0891-5849(00)00307-5. View

Linnane A, Zhang C, Yarovaya N, Kopsidas G, Kovalenko S, Papakostopoulos P . Human aging and global function of coenzyme Q10. Ann N Y Acad Sci. 2002; 959:396-411; discussion 463-5. DOI: 10.1111/j.1749-6632.2002.tb02110.x. View

Boutet M, Huttner I, Rona G . Permeability alteration of sarcolemmal membrane in catecholamine-induced cardiac muscle cell injury. In vivo studies with fine structural diffusion tracer horse radish peroxidase. Lab Invest. 1976; 34(5):482-8. View

Turunen M, Olsson J, Dallner G . Metabolism and function of coenzyme Q. Biochim Biophys Acta. 2004; 1660(1-2):171-99. DOI: 10.1016/j.bbamem.2003.11.012. View

Lee C, Pugh T, Klopp R, Edwards J, Allison D, Weindruch R . The impact of alpha-lipoic acid, coenzyme Q10 and caloric restriction on life span and gene expression patterns in mice. Free Radic Biol Med. 2004; 36(8):1043-57. DOI: 10.1016/j.freeradbiomed.2004.01.015. View

10.

Goldspink D, Burniston J, Ellison G, Clark W, Tan L . Catecholamine-induced apoptosis and necrosis in cardiac and skeletal myocytes of the rat in vivo: the same or separate death pathways?. Exp Physiol. 2004; 89(4):407-16. DOI: 10.1113/expphysiol.2004.027482. View

11.

Geng B, Chang L, Pan C, Qi Y, Zhao J, Pang Y . Endogenous hydrogen sulfide regulation of myocardial injury induced by isoproterenol. Biochem Biophys Res Commun. 2004; 318(3):756-63. DOI: 10.1016/j.bbrc.2004.04.094. View

12.

Ochoa J, Quiles J, Huertas J, Mataix J . Coenzyme Q10 protects from aging-related oxidative stress and improves mitochondrial function in heart of rats fed a polyunsaturated fatty acid (PUFA)-rich diet. J Gerontol A Biol Sci Med Sci. 2005; 60(8):970-5. DOI: 10.1093/gerona/60.8.970. View

13.

Li D, Qu Y, Tao L, Liu H, Hu A, Gao F . Inhibition of iNOS protects the aging heart against beta-adrenergic receptor stimulation-induced cardiac dysfunction and myocardial ischemic injury. J Surg Res. 2005; 131(1):64-72. DOI: 10.1016/j.jss.2005.06.038. View

14.

Sun Y, Carretero O, Xu J, Rhaleb N, Wang F, Lin C . Lack of inducible NO synthase reduces oxidative stress and enhances cardiac response to isoproterenol in mice with deoxycorticosterone acetate-salt hypertension. Hypertension. 2005; 46(6):1355-61. PMC: 4601605. DOI: 10.1161/01.HYP.0000192651.06674.3f. View

15.

Karthikeyan K, Bai B, Niranjali Devaraj S . Cardioprotective effect of grape seed proanthocyanidins on isoproterenol-induced myocardial injury in rats. Int J Cardiol. 2006; 115(3):326-33. DOI: 10.1016/j.ijcard.2006.03.016. View

16.

Gauthaman K, Saleem M, Thanislas P, Prabhu V, Krishnamoorthy K, Devaraj N . Cardioprotective effect of the Hibiscus rosa sinensis flowers in an oxidative stress model of myocardial ischemic reperfusion injury in rat. BMC Complement Altern Med. 2006; 6:32. PMC: 1592511. DOI: 10.1186/1472-6882-6-32. View

17.

Takimoto E, Kass D . Role of oxidative stress in cardiac hypertrophy and remodeling. Hypertension. 2006; 49(2):241-8. DOI: 10.1161/01.HYP.0000254415.31362.a7. View

18.

Littarru G, Tiano L . Bioenergetic and antioxidant properties of coenzyme Q10: recent developments. Mol Biotechnol. 2007; 37(1):31-7. DOI: 10.1007/s12033-007-0052-y. View

19.

Zhang J, Knapton A, Lipshultz S, Weaver J, Herman E . Isoproterenol-induced cardiotoxicity in sprague-dawley rats: correlation of reversible and irreversible myocardial injury with release of cardiac troponin T and roles of iNOS in myocardial injury. Toxicol Pathol. 2008; 36(2):277-8. DOI: 10.1177/0192623307313010. View

20.

Bujak M, Kweon H, Chatila K, Li N, Taffet G, Frangogiannis N . Aging-related defects are associated with adverse cardiac remodeling in a mouse model of reperfused myocardial infarction. J Am Coll Cardiol. 2008; 51(14):1384-92. PMC: 3348616. DOI: 10.1016/j.jacc.2008.01.011. View